Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1995 Aug;4(8):1478–1489. doi: 10.1002/pro.5560040805

Solution structure of the potassium channel inhibitor agitoxin 2: caliper for probing channel geometry.

A M Krezel 1, C Kasibhatla 1, P Hidalgo 1, R MacKinnon 1, G Wagner 1
PMCID: PMC2143198  PMID: 8520473

Abstract

The structure of the potassium channel blocker agitoxin 2 was solved by solution NMR methods. The structure consists of a triple-stranded antiparallel beta-sheet and a single helix covering one face of the beta-sheet. The cysteine side chains connecting the beta-sheet and the helix form the core of the molecule. One edge of the beta-sheet and the adjacent face of the helix form the interface with the Shaker K+ channel. The fold of agitoxin is homologous to the previously determined folds of scorpion venom toxins. However, agitoxin 2 differs significantly from the other channel blockers in the specificity of its interactions. This study was thus focused on a precise characterization of the surface residues at the face of the protein interacting with the Shaker K+ channel. The rigid toxin molecule can be used to estimate dimensions of the potassium channel. Surface-exposed residues, Arg24, Lys27, and Arg31 of the beta-sheet, have been identified from mutagenesis studies as functionally important for blocking the Shaker K+ channel. The sequential and spatial locations of Arg24 and Arg31 are not conserved among the homologous toxins. Knowledge on the details of the channel-binding sites of agitoxin 2 formed a basis for site-directed mutagenesis studies of the toxin and the K+ channel sequences. Observed interactions between mutated toxin and channel are being used to elucidate the channel structure and mechanisms of channel-toxin interactions.

Full Text

The Full Text of this article is available as a PDF (5.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aurora R., Srinivasan R., Rose G. D. Rules for alpha-helix termination by glycine. Science. 1994 May 20;264(5162):1126–1130. doi: 10.1126/science.8178170. [DOI] [PubMed] [Google Scholar]
  2. Bonmatin J. M., Bonnat J. L., Gallet X., Vovelle F., Ptak M., Reichhart J. M., Hoffmann J. A., Keppi E., Legrain M., Achstetter T. Two-dimensional 1H NMR study of recombinant insect defensin A in water: resonance assignments, secondary structure and global folding. J Biomol NMR. 1992 May;2(3):235–256. doi: 10.1007/BF01875319. [DOI] [PubMed] [Google Scholar]
  3. Bontems F., Gilquin B., Roumestand C., Ménez A., Toma F. Analysis of side-chain organization on a refined model of charybdotoxin: structural and functional implications. Biochemistry. 1992 Sep 1;31(34):7756–7764. doi: 10.1021/bi00149a003. [DOI] [PubMed] [Google Scholar]
  4. Bontems F., Roumestand C., Boyot P., Gilquin B., Doljansky Y., Menez A., Toma F. Three-dimensional structure of natural charybdotoxin in aqueous solution by 1H-NMR. Charybdotoxin possesses a structural motif found in other scorpion toxins. Eur J Biochem. 1991 Feb 26;196(1):19–28. doi: 10.1111/j.1432-1033.1991.tb15780.x. [DOI] [PubMed] [Google Scholar]
  5. Bontems F., Roumestand C., Gilquin B., Ménez A., Toma F. Refined structure of charybdotoxin: common motifs in scorpion toxins and insect defensins. Science. 1991 Dec 6;254(5037):1521–1523. doi: 10.1126/science.1720574. [DOI] [PubMed] [Google Scholar]
  6. Fernández I., Romi R., Szendeffy S., Martin-Eauclaire M. F., Rochat H., Van Rietschoten J., Pons M., Giralt E. Kaliotoxin (1-37) shows structural differences with related potassium channel blockers. Biochemistry. 1994 Nov 29;33(47):14256–14263. doi: 10.1021/bi00251a038. [DOI] [PubMed] [Google Scholar]
  7. Garcia M. L., Garcia-Calvo M., Hidalgo P., Lee A., MacKinnon R. Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. Biochemistry. 1994 Jun 7;33(22):6834–6839. doi: 10.1021/bi00188a012. [DOI] [PubMed] [Google Scholar]
  8. Giangiacomo K. M., Garcia M. L., McManus O. B. Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry. 1992 Jul 28;31(29):6719–6727. doi: 10.1021/bi00144a011. [DOI] [PubMed] [Google Scholar]
  9. Havel T. F. An evaluation of computational strategies for use in the determination of protein structure from distance constraints obtained by nuclear magnetic resonance. Prog Biophys Mol Biol. 1991;56(1):43–78. doi: 10.1016/0079-6107(91)90007-f. [DOI] [PubMed] [Google Scholar]
  10. Hidalgo P., MacKinnon R. Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor. Science. 1995 Apr 14;268(5208):307–310. doi: 10.1126/science.7716527. [DOI] [PubMed] [Google Scholar]
  11. Hyberts S. G., Goldberg M. S., Havel T. F., Wagner G. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci. 1992 Jun;1(6):736–751. doi: 10.1002/pro.5560010606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson B. A., Stevens S. P., Williamson J. M. Determination of the three-dimensional structure of margatoxin by 1H, 13C, 15N triple-resonance nuclear magnetic resonance spectroscopy. Biochemistry. 1994 Dec 20;33(50):15061–15070. doi: 10.1021/bi00254a015. [DOI] [PubMed] [Google Scholar]
  13. Johnson B. A., Sugg E. E. Determination of the three-dimensional structure of iberiotoxin in solution by 1H nuclear magnetic resonance spectroscopy. Biochemistry. 1992 Sep 8;31(35):8151–8159. doi: 10.1021/bi00150a006. [DOI] [PubMed] [Google Scholar]
  14. MacKinnon R., Miller C. Functional modification of a Ca2+-activated K+ channel by trimethyloxonium. Biochemistry. 1989 Oct 3;28(20):8087–8092. doi: 10.1021/bi00446a019. [DOI] [PubMed] [Google Scholar]
  15. MacKinnon R., Miller C. Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J Gen Physiol. 1988 Mar;91(3):335–349. doi: 10.1085/jgp.91.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miller C. Competition for block of a Ca2(+)-activated K+ channel by charybdotoxin and tetraethylammonium. Neuron. 1988 Dec;1(10):1003–1006. doi: 10.1016/0896-6273(88)90157-2. [DOI] [PubMed] [Google Scholar]
  17. Park C. S., Hausdorff S. F., Miller C. Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2046–2050. doi: 10.1073/pnas.88.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. RAMACHANDRAN G. N., RAMAKRISHNAN C., SASISEKHARAN V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 1963 Jul;7:95–99. doi: 10.1016/s0022-2836(63)80023-6. [DOI] [PubMed] [Google Scholar]
  19. Stampe P., Kolmakova-Partensky L., Miller C. Intimations of K+ channel structure from a complete functional map of the molecular surface of charybdotoxin. Biochemistry. 1994 Jan 18;33(2):443–450. doi: 10.1021/bi00168a008. [DOI] [PubMed] [Google Scholar]
  20. Wagner G., Wüthrich K. Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Basic pancreatic trypsin inhibitor. J Mol Biol. 1982 Mar 5;155(3):347–366. doi: 10.1016/0022-2836(82)90009-2. [DOI] [PubMed] [Google Scholar]
  21. Withka J. M., Wyss D. F., Wagner G., Arulanandam A. R., Reinherz E. L., Recny M. A. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. Structure. 1993 Sep 15;1(1):69–81. doi: 10.1016/0969-2126(93)90009-6. [DOI] [PubMed] [Google Scholar]
  22. Zhao B., Carson M., Ealick S. E., Bugg C. E. Structure of scorpion toxin variant-3 at 1.2 A resolution. J Mol Biol. 1992 Sep 5;227(1):239–252. doi: 10.1016/0022-2836(92)90694-f. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES